TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
BLTE

Belite Bio Inc

Healthcare · Biotechnology

166.70$ +0.4% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BLTE
Line item 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
99.7% 95.0% 96.7% 95.0% 96.7% 63.3%
99.5% 94.5% 95.1% 93.1% 20.8% 45.2%
99.5% 94.5% 95.1% 93.1% 95.4% 63.1%
0.2% 0.1% 0.0% 0.9% 0.4% 0.1%
– – 0.0% – – –
0.2% 0.5% – – – –
– – 0.1% 3.5% 2.6% 0.6%
127.3% 182.3% 6.3% 4.4% 4.1% 1.3%
3.8% 8.9% 4.8% 3.8% 4.0% 1.3%
– – 0.4% 0.3% 0.2% 0.0%
-27.3% -82.3% 93.7% 95.6% 95.9% 98.7%
-68.2% -148.4% -90.1% -75.6% -70.8% -23.7%
35.8% 131.3% 45.1% 28.1% 20.1% 4.3%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?